Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 25 | $1,182,489 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 26 Mar 2025 16:30 | TRVI | Trevi Therapeutics Inc | SCIASCIA THOMAS | Chief Scientific Officer | 25 Mar 2025 | Sale | 2,631 | 6.6 | 17,365 | D |
| 25 Mar 2025 16:30 | TRVI | Trevi Therapeutics Inc | GOOD JENNIFER L | President & CEO | 21 Mar 2025 | Sale | 5,263 | 6.5789 | 34,625 | D |
| 12 Mar 2025 16:00 | TRVI | Trevi Therapeutics Inc | SIMON FARRELL | Chief Commercial Officer | 10 Mar 2025 | Sale | 76,963 | 6.7276 | 517,776 | D |
| 12 Mar 2025 16:00 | TRVI | Trevi Therapeutics Inc | SIMON FARRELL | Chief Commercial Officer | 10 Mar 2025 | Sale | 4,350 | 7.1498 | 31,102 | D |
| 09 Sep 2024 17:00 | TRVI | Trevi Therapeutics Inc | GOOD JENNIFER L | President & CEO | 09 Sep 2024 | Sale | 1,840 | 3.0362 | 5,587 | D |
| 09 Sep 2024 17:00 | TRVI | Trevi Therapeutics Inc | GOOD JENNIFER L | President & CEO | 06 Sep 2024 | Sale | 4,219 | 3.0302 | 12,784 | D |
| 05 Sep 2024 16:54 | TRVI | Trevi Therapeutics Inc | GOOD JENNIFER L | President & CEO | 05 Sep 2024 | Sale | 40,277 | 3.1112 | 125,310 | D |
| 05 Sep 2024 16:54 | TRVI | Trevi Therapeutics Inc | GOOD JENNIFER L | President & CEO | 04 Sep 2024 | Sale | 10,981 | 3.0239 | 33,205 | D |
| 05 Sep 2024 16:54 | TRVI | Trevi Therapeutics Inc | GOOD JENNIFER L | President & CEO | 03 Sep 2024 | Sale | 3,863 | 3.0229 | 11,677 | D |
| 29 Aug 2024 16:55 | TRVI | Trevi Therapeutics Inc | MEEKER DAVID P | Director | 27 Aug 2024 | Sale | 4,555 | 2.9314 | 13,353 | D |
| 21 Aug 2024 16:00 | TRVI | Trevi Therapeutics Inc | SCIASCIA THOMAS | Chief Scientific Officer | 19 Aug 2024 | Sale | 16,496 | 2.9633 | 48,883 | D |
| 16 Aug 2024 16:47 | TRVI | Trevi Therapeutics Inc | SCIASCIA THOMAS | Chief Scientific Officer | 16 Aug 2024 | Sale | 18,660 | 2.7567 | 51,440 | D |
| 16 Aug 2024 16:47 | TRVI | Trevi Therapeutics Inc | SCIASCIA THOMAS | Chief Scientific Officer | 15 Aug 2024 | Sale | 12,745 | 2.7864 | 35,513 | D |
| 16 Aug 2024 16:47 | TRVI | Trevi Therapeutics Inc | SCIASCIA THOMAS | Chief Scientific Officer | 14 Aug 2024 | Sale | 100 | 2.75 | 275 | D |
| 31 May 2024 16:07 | TRVI | Trevi Therapeutics Inc | SCIASCIA THOMAS | Chief Scientific Officer | 29 May 2024 | Sale | 53,368 | 2.5504 | 136,110 | D |
| 24 May 2024 16:12 | TRVI | Trevi Therapeutics Inc | DELFINI LISA | Chief Financial Officer | 22 May 2024 | Sale | 4,350 | 2.6402 | 11,485 | D |
| 22 May 2024 16:30 | TRVI | Trevi Therapeutics Inc | GOOD JENNIFER L | President & CEO | 20 May 2024 | Sale | 25,037 | 2.8588 | 71,576 | D |
| 14 May 2024 16:51 | TRVI | Trevi Therapeutics Inc | GOOD JENNIFER L | President & CEO | 10 May 2024 | Sale | 4,578 | 2.9 | 13,276 | D |
| 12 Oct 2023 16:00 | TRVI | Trevi Therapeutics Inc | DELFINI LISA | Chief Financial Officer | 11 Oct 2023 | Sale | 785 | 2.02 | 1,586 | D |
| 13 Sep 2023 16:06 | TRVI | Trevi Therapeutics Inc | DELFINI LISA | Chief Financial Officer | 11 Sep 2023 | Sale | 711 | 2.2 | 1,564 | D |
| 14 Aug 2023 16:00 | TRVI | Trevi Therapeutics Inc | DELFINI LISA | Chief Financial Officer | 11 Aug 2023 | Sale | 682 | 2.36 | 1,610 | D |
| 12 Jul 2023 16:29 | TRVI | Trevi Therapeutics Inc | DELFINI LISA | Chief Financial Officer | 11 Jul 2023 | Sale | 687 | 2.34 | 1,608 | D |
| 14 Jun 2023 16:28 | TRVI | Trevi Therapeutics Inc | DELFINI LISA | Chief Financial Officer | 12 Jun 2023 | Sale | 610 | 2.64 | 1,610 | D |
| 15 May 2023 16:00 | TRVI | Trevi Therapeutics Inc | DELFINI LISA | Chief Financial Officer | 11 May 2023 | Sale | 562 | 2.89 | 1,624 | D |
| 12 Apr 2023 17:02 | TRVI | Trevi Therapeutics Inc | DELFINI LISA | Chief Financial Officer | 11 Apr 2023 | Sale | 840 | 1.839 | 1,545 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)